Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat ...

The global report for Risk Analytics Market is slated to expand from USD 32.25 billion in 2025 to USD 51.34 billion by 2030 at an impressive CAGR of 9.7% over the forecast period, according to new ...

Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission ...

Exciting news: metro.news has merged with metro.co.uk! That means that as well as keeping up with all the latest news and features you love from Metro Newspaper you’ll also be joining the 23 ...

BDC-3042 showed biological activity, with clear dose-dependent increases in proinflammatory cytokines and chemokines BDC-3042 showed signs of anti-tumor activity, including an unconfirmed partial ...